Beware, counterfeit Meronem 1g Injection is in circulation, NAFDAC warns

The notification of this product is contained in a public alert No. 036/2023, signed by the Director-General of the agency, Prof. Mojisola Adeyeye, on Tuesday, in Abuja.

Adeyeye said that the agency was equally notified about the injection by the Marketing Authorisation Holder Pfizer, who reported the incident, as received through a patient notification platform.